AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: spiperone
Target: 5-hydroxytryptamine receptor 6 (GPCR)
Gene: HTR6
UniProt: P50406 (5HT6R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.8
Assay: Binding affinity towards human 5-hydroxytryptamine 6 receptor
Drug: spiperone
Target: 5-hydroxytryptamine receptor 7 (GPCR)
Gene: HTR7
UniProt: P34969 (5HT7R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.96
Assay: Binding affinity towards human 5-hydroxytryptamine 7 receptor
Drug: spiperone
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: ADRA1A
UniProt: P35348 (ADA1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.1
Assay: Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug: spiperone
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.92
Assay: Displacement of [3H]Spiperone from human recombinant dopamine D3 receptor expressed in CHO cells after 2 hrs
Drug: spiperone
Target: D(1B) dopamine receptor (GPCR)
Gene: DRD5
UniProt: P21918 (DRD5_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.3
Action type: ANTAGONIST
Drug: spiperone
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P35367 (HRH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.322
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1D (GPCR)
Gene: HTR1D
UniProt: P28221 (5HT1D_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6
Action type: ANTAGONIST
Drug: spiperone
Target: D(4) dopamine receptor (GPCR)
Gene: DRD4
UniProt: P21917 (DRD4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.7
Assay: Displacement of [3H]Spiperone from human recombinant dopamine D4 receptor expressed in CHOK1 cells after 2 hrs
Drug: spiperone
Target: Alpha-1D adrenergic receptor (GPCR)
Gene: ADRA1D
UniProt: P25100 (ADA1D_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.1
Action type: ANTAGONIST
Drug: spiperone
Target: Alpha-1B adrenergic receptor (GPCR)
Gene: ADRA1B
UniProt: P35368 (ADA1B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.2
Action type: ANTAGONIST
Drug: spiperone
Target: 5-hydroxytryptamine receptor 5A (GPCR)
Gene: HTR5A
UniProt: P47898 (5HT5A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.2
Assay: Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1F (GPCR)
Gene: HTR1F
UniProt: P30939 (5HT1F_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.4
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1E (GPCR)
Gene: HTR1E
UniProt: P28566 (5HT1E_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.297
Drug: spiperone
Target: Alpha-1B adrenergic receptor (GPCR)
Gene: Adra1b
UniProt: P15823 (ADA1B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.89
Assay: Overall binding displacement in tissues containing only the Alpha-1B adrenergic receptor (rat spleen, rat liver)
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1B (GPCR)
Gene: Htr1b
UniProt: P28564 (5HT1B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.32
Assay: Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.
Drug: spiperone
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: Adra1a
UniProt: P43140 (ADA1A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.14
Assay: Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug: spiperone
Target: Alpha-1D adrenergic receptor (GPCR)
Gene: Adra1d
UniProt: P23944 (ADA1D_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.66
Drug: spiperone
Target: D(2) dopamine receptor (GPCR)
Gene: Drd2
UniProt: P61169 (DRD2_RAT)
Organism: Rattus norvegicus
Activity: Ki = 10.82
Assay: Competitive binding assay against Dopamine receptor D2 in rat striatal membranes and [125I]-IBF radioligand
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.52
Assay: Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT
Drug: spiperone
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: Htr2a
UniProt: P14842 (5HT2A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9
Assay: Displacement of [3H]ketanserin from rat 5HT2A receptor expressed in mouse NIH3T3 cells
Drug: spiperone
Target: 5-hydroxytryptamine receptor 7 (GPCR)
Gene: Htr7
UniProt: P32305 (5HT7R_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8
Assay: Binding affinity towards rat 5-hydroxytryptamine 7 receptor
Drug: spiperone
Target: 5-hydroxytryptamine receptor 7 (GPCR)
Gene: Htr7
UniProt: P32304 (5HT7R_MOUSE)
Organism: Mus musculus
Activity: Ki = 7.2
Assay: Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand
Drug: spiperone
Target: 5-hydroxytryptamine receptor 2C (GPCR)
Gene: Htr2c
UniProt: P08909 (5HT2C_RAT)
Organism: Rattus norvegicus
Activity: Ki = 6
Assay: Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand
Drug: spiperone
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: ADRA1A
UniProt: P18130 (ADA1A_BOVIN)
Organism: Bos taurus
Activity: Ki = 7.87
Drug: spiperone
Target: 5-hydroxytryptamine receptor 6 (GPCR)
Gene: Htr6
UniProt: P31388 (5HT6R_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.8
Action type: ANTAGONIST
Drug: spiperone
Target: Vesicular acetylcholine transporter (Transporter)
Gene: Slc18a3
UniProt: Q62666 (VACHT_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.99
Assay: Displacement of [125I]O-iodo-trans-decalinvesamicol from VAChT in Sprague-Dawley rat cerebral membrane after 1 hr by gamma counting
Drug: spiperone
Target: Muscarinic acetylcholine receptor (GPCR)
Gene: Chrm1|Chrm3|Chrm4|Chrm5|Chrm2
UniProt: P08482|P08483|P08485|P08911|P10980 (ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT)
Organism: Rattus norvegicus
Activity: Ki = 4.3
Assay: Displacement of [3H]- QNB binding at the muscarinic-cholinergic binding site of rat brain S1
Drug: spiperone
Target: Serotonin 1 (5-HT1) receptor (GPCR)
Gene: Htr1a|Htr1b|Htr1d|Htr1f
UniProt: P19327|P28564|P28565|P30940 (5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT)
Organism: Rattus norvegicus
Activity: Ki = 6.8
Assay: Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.
Drug: spiperone
Target: Dopamine receptor (GPCR)
Gene: Drd1|Drd3|Drd5|Drd4|Drd2
UniProt: P18901|P19020|P25115|P30729|P61169 (DRD1_RAT|DRD3_RAT|DRD5_RAT|DRD4_RAT|DRD2_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.7
Assay: Displacement of [3H]- spiperone radioligand binding at the dopamine binding site of rat caudate
Drug: spiperone
Target: Sodium channel alpha subunits; brain (Types I, II, III) (Ion channel)
Gene: SCN1A|SCN2A|SCN3A
UniProt: P35498|Q99250|Q9NY46 (SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.22
Assay: Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex
Drug: spiperone
Target: Serotonin 2 (5-HT2) receptor (GPCR)
Gene: Htr2c|Htr2a|Htr2b
UniProt: P08909|P14842|P30994 (5HT2C_RAT|5HT2A_RAT|5HT2B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.35
Assay: The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand
Drug: spiperone
Target: Dopamine receptor (GPCR)
Gene: Drd3|Drd4|Drd2|Drd1|Drd5
UniProt: P30728|P51436|P61168|Q61616|Q8BLD9 (DRD3_MOUSE|DRD4_MOUSE|DRD2_MOUSE|DRD1_MOUSE|DRD5_MOUSE)
Organism: Mus musculus
Activity: IC50 = 4.46
Assay: Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to Dopamine receptor of mice
Drug: spiperone
Target: Beta-casein (Unclassified)
Gene: Csn2
UniProt: P02665 (CASB_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.81
Drug: spiperone
Target: 5-hydroxytryptamine receptor 1B (GPCR)
Gene: Htr1b
UniProt: P28334 (5HT1B_MOUSE)
Organism: Mus musculus
Activity: Ki = 8.3
Action type: ANTAGONIST
Drug: spiperone
Target: HLA class I histocompatibility antigen, A-3 alpha chain (Unclassified)
Gene: HLA-A
UniProt: P04439 (1A03_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.6
Assay: Binding affinity to human biotinylated HLA-A2 by surface plasmon resonance assay
Drug: spirapril
Target: Angiotensin-converting enzyme (Enzyme)
Gene: ACE
UniProt: P12821 (ACE_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9.1
Action type: INHIBITOR
Assay: Compound tested in vitro for inhibition of Angiotensin I converting enzyme
Drug: spirapril
Target: Angiotensin-converting enzyme (Enzyme)
Gene: Ace
UniProt: P47820 (ACE_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 7.17
Assay: Compound tested in vitro for inhibition of Angiotensin I converting enzyme
Drug: spironolactone
Target: Glucocorticoid receptor (Nuclear hormone receptor)
Gene: NR3C1
UniProt: P04150 (GCR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.227
Drug: spironolactone
Target: Nuclear receptor subfamily 1 group I member 2 (Nuclear hormone receptor)
Gene: NR1I2
UniProt: O75469 (NR1I2_HUMAN)
Organism: Homo sapiens
Drug: spironolactone
Target: Mineralocorticoid receptor (Nuclear hormone receptor)
Gene: NR3C2
UniProt: P08235 (MCR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9.884
Action type: ANTAGONIST
Drug: spironolactone
Target: Androgen receptor (Nuclear hormone receptor)
Gene: AR
UniProt: P10275 (ANDR_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.4
Assay: Binding affinity to human androgen receptor
Drug: spironolactone
Target: Progesterone receptor (Nuclear hormone receptor)
Gene: PGR
UniProt: P06401 (PRGR_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.029
Drug: spironolactone
Target: Estrogen receptor beta (Nuclear hormone receptor)
Gene: ESR2
UniProt: Q92731 (ESR2_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 5.48
Assay: Agonist activity at estrogen receptor beta (unknown origin) by NH Pro assay
Drug: spironolactone
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.523
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: spironolactone
Target: Androgen receptor (Transcription factor)
Gene: Ar
UniProt: P15207 (ANDR_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 6.17
Assay: Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)
Drug: spironolactone
Target: Progesterone receptor (Transcription factor)
Gene: PGR
UniProt: Q690N0 (Q690N0_BOVIN)
Organism: Bos taurus
Activity: Ki = 6.663
Assay: DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)
Drug: spironolactone
Target: Multidrug and toxin extrusion protein 1 (Transporter)
Gene: SLC47A1
UniProt: Q96FL8 (S47A1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.73
Assay: Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
Drug: stanozolol
Target: Cytochrome P450 2D6 (Enzyme)
Gene: CYP2D6
UniProt: P10635 (CP2D6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.033
Assay: DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: stanozolol
Target: Adenosine receptor A3 (GPCR)
Gene: ADORA3
UniProt: P0DMS8 (AA3R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.327
Assay: DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)
Drug: stanozolol
Target: Estrogen receptor (Nuclear hormone receptor)
Gene: ESR1
UniProt: P03372 (ESR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.495
Assay: DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)
Drug: stanozolol
Target: Androgen receptor (Nuclear hormone receptor)
Gene: AR
UniProt: P10275 (ANDR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action; CHEMBL1871; SINGLE PROTEIN
Drug: stanozolol
Target: Cytochrome P450 2C9 (Enzyme)
Gene: CYP2C9
UniProt: P11712 (CP2C9_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.948
Assay: DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: stanozolol
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.319
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: stanozolol
Target: Androgen receptor (Transcription factor)
Gene: Ar
UniProt: P15207 (ANDR_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.824
Assay: DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)
Drug: stanozolol
Target: Progesterone receptor (Transcription factor)
Gene: PGR
UniProt: Q690N0 (Q690N0_BOVIN)
Organism: Bos taurus
Activity: Ki = 6.316
Assay: DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)
Drug: stavudine
Target: Gag-Pol polyprotein (Polyprotein)
Gene: gag-pol
UniProt: P03369 (POL_HV1A2)
Organism: Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
Drug: stavudine
Target: Reverse transcriptase/RNaseH (Enzyme)
Gene: pol
UniProt: Q72547 (Q72547_9HIV1)
Organism: Human immunodeficiency virus 1
Activity: EC50 = 7.3
Action type: INHIBITOR
Assay: Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.
Drug: stavudine
Target: Reverse transcriptase (Enzyme)
Gene: reverse transcriptas
UniProt: Q9WKE8 (Q9WKE8_9HIV1)
Organism: Human immunodeficiency virus 1
Activity: IC50 = 7.22
Assay: Inhibition of HIV1 reverse transcriptase
Drug: stiripentol
Target: Cytochrome P450 3A4 (Enzyme)
Gene: CYP3A4
UniProt: P08684 (CP3A4_HUMAN)
Organism: Homo sapiens
Drug: stiripentol
Target: Sodium- and chloride-dependent GABA transporter 1 (Transporter)
Gene: SLC6A1
UniProt: P30531 (SC6A1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.3
Drug: stiripentol
Target: Cytochrome P450 1A2 (Enzyme)
Gene: CYP1A2
UniProt: P05177 (CP1A2_HUMAN)
Organism: Homo sapiens
Drug: stiripentol
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Drug: streptomycin
Target: 30S ribosomal protein S12 (Ribosomal protein)
Gene: rpsL
UniProt: P9WH62 (RS12_MYCTO)
Organism: Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
Drug: strychnine
Target: Muscarinic acetylcholine receptor M1 (GPCR)
Gene: CHRM1
UniProt: P11229 (ACM1_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5
Action type: ALLOSTERIC MODULATOR
Drug: strychnine
Target: Muscarinic acetylcholine receptor M2 (GPCR)
Gene: CHRM2
UniProt: P08172 (ACM2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5
Action type: ALLOSTERIC MODULATOR
Drug: strychnine
Target: Muscarinic acetylcholine receptor M3 (GPCR)
Gene: CHRM3
UniProt: P20309 (ACM3_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5.7
Action type: ALLOSTERIC MODULATOR
Drug: strychnine
Target: Muscarinic acetylcholine receptor M4 (GPCR)
Gene: CHRM4
UniProt: P08173 (ACM4_HUMAN)
Organism: Homo sapiens
Activity: Kd = 5
Action type: ALLOSTERIC MODULATOR
Drug: strychnine
Target: Glycine receptor subunit alpha-1 (Ion channel)
Gene: GLRA1
UniProt: P23415 (GLRA1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.7
Assay: GRAC: human Glycine receptor subunit alpha-1 selective antagonist
Drug: strychnine
Target: Sodium channel alpha subunits; brain (Types I, II, III) (Ion channel)
Gene: SCN1A|SCN2A|SCN3A
UniProt: P35498|Q99250|Q9NY46 (SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.68
Assay: Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex
Drug: strychnine
Target: Glycine receptor subunit alpha-1 (Ion channel)
Gene: Glra1
UniProt: P07727 (GLRA1_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.92
Assay: Displacement of [3H]strychnine from glycine receptor alpha 1 in rat brain synaptic membranes
Drug: strychnine
Target: Taste receptor type 2 member 10 (GPCR)
Gene: TAS2R10
UniProt: Q9NYW0 (T2R10_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 5.3
Assay: Activity at human TAS2R10 expressed in HEK293/15 cells assessed as effect on calcium response by FLIPR assay
Drug: strychnine
Target: Taste receptor type 2 member 46 (GPCR)
Gene: TAS2R46
UniProt: P59540 (T2R46_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.367
Action type: AGONIST
Assay: calcium imaging in ransfected human embryonic kidney (HEK)-293T
Drug: succinic acid
Target: Egl nine homolog 1 (Enzyme)
Gene: EGLN1
UniProt: Q9GZT9 (EGLN1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.52
Assay: Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr
Drug: succinic acid
Target: Succinate receptor 1 (GPCR)
Gene: SUCNR1
UniProt: Q9BXA5 (SUCR1_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.7
Action type: AGONIST
Drug: suxamethonium
Target: Acetylcholinesterase (Enzyme)
Gene: Ache
UniProt: P21836 (ACES_MOUSE)
Organism: Mus musculus
Activity: Ki = 4.68
Assay: Inhibition of mouse AChE
Drug: suxamethonium
Target: Muscle-type nicotinic acetylcholine receptor (Ion channel)
Gene: CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND
UniProt: P02708|P07510|P11230|Q04844|Q07001 (ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP
Drug: sufentanil
Target: Mu-type opioid receptor (GPCR)
Gene: OPRM1
UniProt: P35372 (OPRM_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 8.13
Action type: AGONIST
Drug: sufentanil
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41145 (OPRK_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.7
Drug: sufentanil
Target: Delta-type opioid receptor (GPCR)
Gene: OPRD1
UniProt: P41143 (OPRD_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.301
Drug: sufentanil
Target: Solute carrier family 22 member 1 (Transporter)
Gene: SLC22A1
UniProt: O15245 (S22A1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.71
Assay: Inhibition of human OCT1 expressed in HEK293 cells assessed as reduction in ASP+ substrate uptake by microplate reader based analysis
Drug: sufentanil
Target: Mu-type opioid receptor (GPCR)
Gene: Oprm1
UniProt: P33535 (OPRM_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.66
Assay: Ability to displace [3H]naloxone from the Opioid receptor mu 1 isolated from the rat brain membranes.
Drug: sufentanil
Target: Sigma non-opioid intracellular receptor 1 (Membrane other)
Gene: SIGMAR1
UniProt: Q60492 (SGMR1_CAVPO)
Organism: Cavia porcellus
Activity: IC50 = 5.68
Assay: Displacement of [3H]pentazocine from LAL/HA/BR guinea pig brain sigma1 receptor incubated for 90 mins by liquid scintillation counting method
Drug: sufentanil
Target: Opioid receptor (GPCR)
Gene: Oprd1|Oprm1|Oprk1|Sigmar1
UniProt: P33533|P33535|P34975|Q9R0C9 (OPRD_RAT|OPRM_RAT|OPRK_RAT|SGMR1_RAT)
Organism: Rattus norvegicus
Activity: Ki = 10.7
Assay: In vitro affinity to displace [3H]naloxone from opiate receptor in freshly prepared rat brain homogenates
Drug: sufentanil
Target: Sigma non-opioid intracellular receptor 1 (Unclassified)
Gene: SIGMAR1
UniProt: Q60492 (SGMR1_CAVPO)
Organism: Cavia porcellus
Activity: IC50 = 5.68
Assay: Displacement of [3H]pentazocine from LAL/HA/BR guinea pig brain sigma1 receptor incubated for 90 mins by liquid scintillation counting method
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: blaZ
UniProt: P00807 (BLAC_STAAU)
Organism: Staphylococcus aureus
Activity: IC50 = 5.19
Assay: Inhibitory activity against Penicillinase from Staphylococcus aureus TH-14 using piperacillin (40 uM) as a substrate
Drug: sulbactam
Target: Beta-lactamase TEM (Enzyme)
Gene: bla; blaT-3; blaT-4;
UniProt: P62593 (BLAT_ECOLX)
Organism: Escherichia coli
Activity: Ki = 6.1
Action type: INHIBITOR
Assay: Inhibition constant (Ki) for TEM-1 beta-lactamase
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: ampC
UniProt: P00811 (AMPC_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 4.18
Assay: Inhibitory activity against AmpC (class C) beta-lactamase
Drug: sulbactam
Target: Beta-lactamase SHV-1 (Enzyme)
Gene: bla
UniProt: P0AD63 (BLA1_ECOLX)
Organism: Escherichia coli
Activity: IC50 = 5.41
Assay: Cell Free Inhibition Assay: The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by determining the concentration of inhibitor at which 50% of the nitrocefin hydrolysis is inhibited by the particular enzyme. Assays are performed with beta -lactamases expressed in the pET system (Novagen, San Diego, Calif.) without signal peptides. They contain an N-terminal hexa-Histidine tag that is used for purification on Ni-NTA (Qiagen, Hilden, Germany). The compounds are prepared as 50 mM stocks in DMSO and diluted into buffer P1 (50 mM phosphate, pH 7) to a final concentration of 10% DMSO. All further dilutions are done in P2 (P1 with 10% DMSO). Enzyme and compound dilutions are pre-incubated for 10 min at 37 C. and the reaction is started with the addition of pre-warmed (37 C.) nitrocefin at a final concentration of 50 mM. The change in absorption at 490 nm is followed at 37 C. for 10 min with
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: ampC
UniProt: P05364 (AMPC_ENTCL)
Organism: Enterobacter cloacae
Activity: IC50 = 6
Assay: Compound was evaluated for beta-lactamase inhibition activity of Escherichia cloacae after 15 min of pre-incubation with the enzyme at 37 degree C
Drug: sulbactam
Target: Beta-lactamase OXA-1 (Enzyme)
Gene: bla
UniProt: P13661 (BLO1_ECOLX)
Organism: Escherichia coli
Activity: IC50 = 4.66
Assay: Inhibitory activity against Beta-lactamase type OXA1 (penicillinase) from Escherichia coli OXA1 using ampicillin (40 uM) as a substrate
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: ampC
UniProt: P24735 (AMPC_PSEAE)
Organism: Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Activity: IC50 = 4.57
Assay: Inhibition of Pseudomonas aeruginosa beta-lactamase AmpC assessed as nitrocefin hydrolysis after 5 mins enzyme-compound preincubation
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: blaSCO-1
UniProt: A1E3K9 (A1E3K9_ECOLX)
Organism: Escherichia coli
Activity: IC50 = 5.21
Assay: Inhibition of Escherichia coli beta-lactamase SCO1
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: bcl1
UniProt: A8RR46 (A8RR46_BACCS)
Organism: Bacillus clausii
Activity: IC50 = 7.12
Assay: Inhibition of Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3)
Drug: sulbactam
Target: Carbapenem-hydrolizing beta-lactamase SFC-1 (Enzyme)
UniProt: Q6JP75 (Q6JP75_SERFO)
Organism: Serratia fonticola
Activity: IC50 = 4.64
Assay: Inhibition of Serratia fonticola UTAD54 SFC1 beta lactamase expressed in Escherichia coli BL21(DE3) by SDS-PAGE
Drug: sulbactam
Target: Beta-lactamase GES-13 (Enzyme)
Gene: blaGES-13
UniProt: D1MIX9 (D1MIX9_PSEAI)
Organism: Pseudomonas aeruginosa
Activity: IC50 = 6.43
Assay: Inhibition of Pseudomonas aeruginosa GES-13 beta lactamase
Drug: sulbactam
Target: Class D beta-lactamase (Unclassified)
Gene: oxa-63
UniProt: Q50H31 (Q50H31_BRAPL)
Organism: Brachyspira pilosicoli
Activity: IC50 = 4.92
Assay: Inhibition of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as reduction in nitrocefin hydrolysis by spectrophotometry relative to oxacillin
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: SHV-11
UniProt: Q7X575 (Q7X575_ECOLX)
Organism: Escherichia coli
Activity: IC50 = 5.62
Assay: Inhibition of Escherichia coli JM109 beta-lactamase SHV-11
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: adc-14
UniProt: Q0VTR6 (Q0VTR6_ACIPI)
Organism: Acinetobacter pittii
Activity: IC50 = 5.95
Assay: Inhibition of Acinetobacter genomosp. 3 isolate 65 ADC-14
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: adc-16
UniProt: Q0VTR8 (Q0VTR8_ACIPI)
Organism: Acinetobacter pittii
Activity: IC50 = 5.11
Assay: Inhibition of Acinetobacter genomosp. 3 isolate 103 ADC-16
Drug: sulbactam
Target: Beta-lactamase (Enzyme)
Gene: blaPER-6
UniProt: D5HSX5 (D5HSX5_9GAMM)
Organism: Aeromonas allosaccharophila
Activity: IC50 = 5.4
Assay: Inhibition of Aeromonas allosaccharophila AL-1 beta-lactamase PER6
Drug: sulbactam
Target: Serine beta-lactamase-like protein LACTB, mitochondrial (Enzyme)
Gene: LACTB
UniProt: P83111 (LACTB_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.01